/PRNewswire/ Acousia Therapeutics GmbH will be presenting data on the company s clinical stage, first-in-class lead candidate ACOU085 at the Hanson Wade 2nd.
/PRNewswire/ Acousia Therapeutics GmbH – along with its partners from the Translational Hearing Research Group at the Tübingen Hearing Research Center.
TÜBINGEN, Germany, Feb. 4, 2022 /PRNewswire/ Acousia Therapeutics GmbH - along with its partners from the Translational Hearing Research Group at the Tübingen Hearing Research Center (Department
Tübingen, Germany, January 26, 2022 Acousia Therapeutics GmbH – along with its partners from the Translational Hearing Research Group at the Tübingen Hearing Research Center (Department of Otolaryngology, Head and Neck Surgery, University of Tübingen) and Synovo GmbH (Tübingen) – will be presenting data on the Synovia company’s clinical stage lead candidate ACOU085 at the 45th Annual MidWinter Meeting of the Association for Research in Otolaryngology to be held virtually on February 5–9, 2022.
Acousia Therapeutics GmbH – along with its partners from the Translational Hearing Research Group at the Tübingen Hearing Research Center (Department of Otolaryngology, Head and Neck Surgery, University of Tübingen)